Thyroid hormone response elements differentially modulate the interactions of thyroid hormone receptors with two receptor binding domains in the steroid receptor coactivator-1

被引:59
作者
Takeshita, A [1 ]
Yen, PM [1 ]
Ikeda, M [1 ]
Cardona, GR [1 ]
Liu, Y [1 ]
Koibuchi, N [1 ]
Norwitz, ER [1 ]
Chin, WW [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.273.34.21554
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ligand-dependent transcriptional activation by nuclear receptors is mediated by interactions with coactivators. Recently, a consensus interaction motif (LXXLL) has been identified in a number of coactivators such as steroid receptor coactivator-l (SRC-1). SRC-1 contains three such motifs in the central (nuclear receptor binding domain-1, NBD-1) and a single one in the C-terminal (NBD-S) regions. To define the nature and role of the two NBDs in SRC-1, interaction studies between the two NBDs and thyroid hormone receptor (TR) were performed. Although NBD-1 and NBD-S showed similar ligand- and AF-a dependent interactions with TR, in solution, these two NBDs possessed distinct interaction properties with TR when TR is bound to a thyroid hormone-response element (TRE). Both in vitro and in vivo interaction studies demonstrate that NBD-1, but not NBD-2, exhibits ligand-dependent interaction with TR in the presence of TREs. In addition, a natural isoform of SRC-1, SRC-1E, which lacks NBD-2, preserved TR as well as progesterone receptor-mediated coactivator function on reporter gene expression. Finally, we found that NBD-1 failed to interact with a TR and retinoid X receptor heterodimer complex on a transcriptionally inactive direct repeat +4 TRE in electrophoretic mobility shift assays. These observations indicate that DNA-induced, as well as ligand-induced, conformational change(s) of TR may influence the nature of its binding to SRC-1, and that the two NBDs of SRC-I may play different roles to regulate ligand-dependent transactivation of TRs.
引用
收藏
页码:21554 / 21562
页数:9
相关论文
共 52 条
[1]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[2]   INTERACTION OF HUMAN THYROID-HORMONE RECEPTOR-BETA WITH TRANSCRIPTION FACTOR TFIIB MAY MEDIATE TARGET GENE DEREPRESSION AND ACTIVATION BY THYROID-HORMONE [J].
BANIAHMAD, A ;
HA, I ;
REINBERG, D ;
TSAI, S ;
TSAI, MJ ;
OMALLEY, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8832-8836
[3]   CHARACTERIZATION OF THE LIGAND-DEPENDENT TRANSACTIVATION DOMAIN OF THYROID-HORMONE RECEPTOR [J].
BARETTINO, D ;
RUIZ, MDMV ;
STUNNENBERG, HG .
EMBO JOURNAL, 1994, 13 (13) :3039-3049
[4]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[5]   NUCLEAR FACTOR RIP140 MODULATES TRANSCRIPTIONAL ACTIVATION BY THE ESTROGEN-RECEPTOR [J].
CAVAILLES, V ;
DAUVOIS, S ;
LHORSET, F ;
LOPEZ, G ;
HOARE, S ;
KUSHNER, PJ ;
PARKER, MG .
EMBO JOURNAL, 1995, 14 (15) :3741-3751
[6]   Role of CBP/P300 in nuclear receptor signalling [J].
Chakravarti, D ;
LaMorte, VJ ;
Nelson, MC ;
Nakajima, T ;
Schulman, IG ;
Juguilon, H ;
Montminy, M ;
Evans, RM .
NATURE, 1996, 383 (6595) :99-103
[7]   Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 [J].
Chen, HW ;
Lin, RJ ;
Schiltz, RL ;
Chakravarti, D ;
Nash, A ;
Nagy, L ;
Privalsky, ML ;
Nakatani, Y ;
Evans, RM .
CELL, 1997, 90 (03) :569-580
[8]   IDENTIFICATION OF A CONSERVED REGION REQUIRED FOR HORMONE DEPENDENT TRANSCRIPTIONAL ACTIVATION BY STEROID-HORMONE RECEPTORS [J].
DANIELIAN, PS ;
WHITE, R ;
LEES, JA ;
PARKER, MG .
EMBO JOURNAL, 1992, 11 (03) :1025-1033
[9]  
Fondell JD, 1996, MOL CELL BIOL, V16, P281
[10]  
HADZIC E, 1995, MOL CELL BIOL, V15, P4507